Keyphrases
Inflammation
100%
Phosphodiesterase Inhibitors
100%
Toll-like
100%
CAMP Phosphodiesterase
100%
Imiquimod
100%
Macrophages
22%
Phosphodiesterase Inhibition
22%
Inflammatory Cytokines
11%
Adverse Effects
11%
Phosphodiesterase
11%
Inducer
11%
Drug Use
11%
Reduced Expression
11%
Anticancer Drugs
11%
Reporter Assay
11%
Squamous Cell Carcinoma (SqCC)
11%
Isoproterenol
11%
Anti-inflammatory Cytokines
11%
Inflammatory Activity
11%
Interleukin-10
11%
Antiviral Drugs
11%
TLR4 Agonist
11%
Active Sites
11%
Molecular Docking
11%
HEK293 Cells
11%
High-risk Human Papillomavirus (HR-HPV)
11%
Lysate
11%
Enhanced Expression
11%
Basal Cell Carcinoma
11%
CAMP Signaling
11%
RAW264.7 Macrophages
11%
Adrenergic Receptor Agonists
11%
CREB Phosphorylation
11%
Molecular Similarity
11%
Independent Activity
11%
Anti-inflammatory Role
11%
Inflammatory Drugs
11%
Genital Warts
11%
Carcinoma Squamous Cell
11%
Anti-inflammatory Function
11%
Loxoribine
11%
Phosphodiesterase-4 (PDE4)
11%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammation
100%
Phosphodiesterase Inhibitor
100%
Toll Like Receptor 7
100%
Imiquimod
100%
Phosphodiesterase
33%
Anti-Inflammatory Drug
33%
Cytokine
22%
Side Effect
11%
Anticarcinogen
11%
Tumor Necrosis Factor
11%
Interleukin 10
11%
Antivirus Agent
11%
Squamous Cell Carcinoma
11%
Toll Like Receptor 4
11%
Adrenergic Receptor Stimulating Agent
11%
Isoprenaline
11%
Human Papillomavirus
11%
Basal Cell Carcinoma
11%
Condyloma acuminatum
11%
Loxoribine
11%
Adenine
11%
Immunology and Microbiology
Agonist
100%
Imiquimod
100%
Toll-Like Receptor
100%
Macrophage
33%
Tumor Necrosis Factor
11%
Proinflammatory Cytokine
11%
Squamous Cell
11%
TLR4
11%
Inflammatory Cytokine
11%
Interleukin 10
11%
Wart Virus
11%
Basal Cell
11%
Cell Lysate
11%
Molecular Docking
11%
Genital Wart
11%
Loxoribine
11%
Isoprenaline
11%